loader2
Partner With Us NRI

Beta Drugs Ltd share Price Today

Company details

1,204.00
1,273.95
728.00
1,595.00
6M Return -12.12%
1Y Return 63.92%
Mkt Cap.(Cr) 1,213.38
Volume 11,900
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 11,900

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Beta Drugs Ltd shares SWOT Analysis

Strengths (7)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Rising Net Cash Flow and Cash from Operating activity
  • Company with Low Debt

Weakness (3)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (0)

Data not found

Resistance and support

R1 1,289.4
R2 1,316.6
R3 1,359.3
Pivot

1,246.68

S1 1,219.4
S2 1,176.7
S3 1,149.5
EMA SMA
1,214.4
1,231.7
1,244.6
1,196.5
1,208.8
1,227.2
1,257.1
1,247.8
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
BATRA VIJAY KUMAR Bulk Purchase 2020-09-01 84.95 50400 NSE
ONKAR SINGH Bulk Purchase 2020-07-24 96.03 87200 NSE
ADESH VENTURES LLP Bulk Sell 2020-07-24 95.52 108000 NSE
Name Category Shares
Neeraj Batra PROMOTER 65.96%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Beta Drugs Ltd Stocks COMPARISON

Financials( in Cr) Beta Drugs Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 1,262.10 1,579.30 1,510.40 4,570.80 1,184.80
% Change 5.81 -1.20 -0.19 -1.43 0.39
Mcap Cr 1,213.38 378,926.98 121,944.71 121,340.57 119,218.60
Revenue TTM Cr 227.11 48,496.85 15,790.60 7,665.00 19,547.40
Net Profit TTM Cr 30.72 9,648.44 2,513.47 1,576.00 3,854.40
PE TTM 33.30 37.93 28.66 75.74 30.89
1 Year Return 63.92 51.13 48.56 25.57 103.71
ROCE 32.63 17.20 14.76 16.27 23.94
ROE 28.55 16.13 10.66 12.04 20.64
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 122.88 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,424.68 50,451.86
LAST 3M 101,404.97 51,097.20
LAST 6M 186,293.66 40,305.54
LAST 12M 309,547.75 87,515.42

Beta Drugs Ltd Information

Stock PE (TTM)
33.3
Promoter Holding
66.73%
Book Value
163.4254
ROCE
32.63%
ROE
28.55%
Description
  • Beta Drugs Limited was incorporated as a private limited company with the name "Beta Drugs Private limited" at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to "Beta Drugs Limited" on August 11, 2017 Beta Drugs is a part of Adley Group. Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India. The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014. The company is primarily engaged in the manufacturing of oncology products. The Company`s products range from anti-cancer tablets, capsules, injections and lyophilized injections. The Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease. The Company set up the first Oncology Unit in Adley Formulations Pvt Ltd. in 2008. It set up a new "state of the art" manufacturing facility for oncology formulations in 2014; developed in-house Albumin bound Paclitaxel in 2015; started in-house API Plant - Adley Labs in 2017. In October, 2017, the Company came up with a Public Issue of 22,96,000 Equity Shares by raising equity capital aggregating Rs 19.5 Crores. The Company set up an Oncology Plant in Uzbekistan in 2018. In 2020, the Company launched GEM-RTU, ADLEAP, ADLANTE, BEXINIB; launched 1st Indian Brand of Dasatinib, BEEDAN. In 2021, the Company launched 1st Indian brand of Sunitinib, ADSUNIB.

Registered Address

Village Nandpur, , Baddi, Himachal Pradesh, 174101

Tel : 91-1795-236196
Email : info:betadrugslimited.com
Website : http://www.betadrugslimited.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1600
BSE Code : 535022
NSE Code : BETA
Book Closure Date (Month) : Sep
BSE Group :
ISIN : INE351Y01019

FAQ’s on Beta Drugs Ltd Shares

You can buy Beta Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Beta Drugs Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 16, 2024 03:43 PM the closing price of Beta Drugs Ltd was Rs.1,262.10.

The latest PE ratio of Beta Drugs Ltd as of Jul 16, 2024 03:43 PM is 33.30

The latest PB ratio of Beta Drugs Ltd as of Jul 16, 2024 03:43 PM is 0.13

The 52-week high of Beta Drugs Ltd share price is Rs. 1,595.00 while the 52-week low is Rs. 728.00

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 16, 2024 03:43 PM, the market cap of Beta Drugs Ltd stood at Rs. 1,213.38 Cr.

Download App

Download Our App

Play Store App Store
market app